Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
N/A
-886,281 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
N/A
-10,000 Reduced 1.12%
886,281 $15.6 Million
Q2 2021

Aug 13, 2021

SELL
N/A
-426,900 Reduced 32.26%
896,281 $8.69 Million
Q1 2021

May 14, 2021

SELL
N/A
-155,000 Reduced 10.49%
1,323,181 $14.2 Million
Q4 2020

Feb 12, 2021

SELL
N/A
-80,000 Reduced 5.13%
1,478,181 $21.7 Million
Q3 2020

Nov 12, 2020

BUY
N/A
75,000 Added 5.06%
1,558,181 $22.1 Million
Q2 2020

Aug 04, 2020

SELL
N/A
-335,000 Reduced 18.43%
1,483,181 $12 Million
Q1 2020

May 08, 2020

BUY
N/A
1,818,181 New
1,818,181 $7.35 Million

About Trillium Therapeutics Inc.


  • Ticker TRIL
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,995,000
  • Market Cap $1.94B
More about TRIL
Track This Portfolio

Track Fairmount Funds Management LLC Portfolio

Follow Fairmount Funds Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairmount Funds Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fairmount Funds Management LLC with notifications on news.